Stergiou Angelos M.
SEC CIK 1724253 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc. | Pres, CEO, Dir | 1.76M | — | $30.2K | 10 | 2021-12-02 | 2026-06-16 |
Most active insiders at SLS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kalin Katherine Bach | Dir | $100.8K | — |
| 2 | Stergiou Angelos M. | Pres, CEO, Dir | — | — |
| 3 | Burns John Thomas | CFO | — | — |
| 4 | CICIC DRAGAN | SVP, Chief Development Off | — | — |
| 5 | Varian John | Dir | — | — |
| 6 | Wasman Jane | Dir | — | — |
| 7 | SCHEINBERG DAVID A | Dir | — | — |
| 8 | VAN NOSTRAND ROBERT L | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 16:30 | 2026-06-16 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +1.06M | 1.76M | +153% | $0 | |
| 2025-12-05 | 2025-12-03 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | J - Other | $1.50 | -187.1K | 687.0K | -21% | -$280.6K | |
| DM | 2025-01-14 | 2025-01-10 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +500.9K | 615.1K | +438% | $0 |
| 2024-12-05 | 2024-12-04 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | J - Other | $1.13 | -28.3K | 358.1K | -7% | -$32.0K | |
| D | 2024-01-25 | 2024-01-22 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +159.0K | 376.4K | +73% | $0 |
| 2023-12-08 | 2023-12-06 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | J - Other | $1.08 | -12.3K | 217.4K | -5% | -$13.2K | |
| D | 2023-02-03 | 2023-02-02 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +58.0K | 219.7K | +36% | $0 |
| 2022-12-05 | 2022-12-05 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | S - Sale | $2.61 | -6,494 | 161.7K | -4% | -$16.9K | |
| D | 2022-02-01 | 2022-01-31 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +44.0K | 165.2K | +36% | $0 |
| 2021-12-03 | 2021-12-02 | SLS | SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | Pres, CEO, Dir | S - Sale | $6.25 | -2,120 | 121.2K | -2% | -$13.2K |
Purchase Sale Sale after option exercise All abbreviations